From: Screening of selective histone deacetylase inhibitors by proteochemometric modeling
Class I | Â | Class IIa | Â | Class IIb |
---|---|---|---|---|
HDAC2 | HDAC8 | HDAC4 | HDAC7 | HDAC6 |
Pan-HDAC inhibitors | ||||
TSA | ||||
S | W | S | S | S |
−0.720 | 0.342 | 1.027 | 0.660 | 0.087 |
SAHA | ||||
S | W | S | S | S |
−0.464 | −1.092 | 0.687 | 1.031 | −0.094 |
Panbinostat(LBH589) | ||||
S | W | S | S | W |
0.742 | 0.391 | 0.524 | 0.347 | 0.996 |
Belinostat(PXD-101) | ||||
S | W | S | S | S |
0.327 | −0.330 | 1.183 | 0.643 | 1.339 |
Class I-specific inhibitors | ||||
MGCD0103 | ||||
S | N | N | N | N |
0.296 | −0.946 | −0.557 | −1.018 | −0.963 |
depsipeptide(FK228) | ||||
S | nd | W | nd | N |
0.954 | −0.095 | 0.687 | 0.438 | −0.167 |
Apicidin | ||||
S | W | N | N | N |
0.238 | 0.096 | −0.501 | −0.176 | −0.120 |
Class II-specific inhibitors | ||||
APHA | Â | Â | Â | Â |
nd | nd | S | nd | nd |
−0.196 | −0.089 | −0.204 | −0.194 | 0.271 |
Tubacin | ||||
nd | nd | nd | nd | S |
0.148 | −0.687 | −0.293 | −0.301 | 1.414 |
NCT-10a | ||||
nd | nd | W | nd | S |
−0.405 | −0.731 | 0.137 | 0.159 | 0.010 |